Publications database

This poster was presented during the WHO Conference on Prison Health, 11-12 December 2017, Lisbon, Portugal. It presents current available data on prevalence of drug use and expert ratings on the availability...

Comparable and reliable data about the number and characteristics of people entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The primary purpose of the...

High-risk drug use is one of the major causes of avoidable mortality in Europe, both directly through overdose and indirectly through drug-related diseases, accidents, violence and suicide. The primary purpose of the...

The problem drug use (PDU) indicator is one of the five EMCDDA key epidemiological indicators, addressing key aspects of the prevalence and harms of drug use at the European level. National experts...

Injecting drugs is a key risk factor for contracting viral and other infections. Blood-borne infections acquired through the sharing of injecting equipment are among the most serious health harms of drug use...

A Trendspotter study is a rapid information assessment that uses multiple social research methods to explore a topic of interest or concern. The approach was developed and has been used by the...

Knowledge of the extent and patterns of drug use in the general population, and their changes over time, is essential to understanding the drug phenomenon in Europe and to monitoring progress towards...

For more than 20 years, the European information network on drugs and drug addiction (Reitox), has been the cornerstone of the European drug monitoring and reporting system, to which it contributes by...

Drug markets can be seen from the perspective of supply and demand. Market-related indicators, therefore, particularly administrative data, such as seizures, price, purity and drug-related offences, are used in most countries for...

The EU Drug Markets Report 2016 is the second comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. Taking an evidence-based approach, the report considers the...